{"podcast":{"title":"Gynecologic Oncology Update","slug":"gynecologic-oncology-update-612940","podcast_index_feed_id":612940,"rss_url":"https://feeds.captivate.fm/gynecologic-oncology/","website_url":"https://www.researchtopractice.com/browse-tumor-types/ovarian-cancer","image_url":"https://artwork.captivate.fm/aa2bde68-0d40-4e41-b73e-fff33f9524cf/gou-podcast-logo-3000px.png","author":"Dr. Neil Love","episode_count":52,"summary":"This series bridges the gap between research and patient care by providing medical and gynecologic oncologists with access to the latest research developments and expert perspectives on up-to-date clinical management strategies for gynecologic cancers.","last_synced_at":"2026-09-18T02:23:24.296340+00:00","page_url":"https://stenobird.com/podcast/gynecologic-oncology-update-612940"},"episode":{"title":"Low-Grade Serous Ovarian Cancer — Rapid Case Review: Microlearning Activity 2","slug":"low-grade-serous-ovarian-cancer-rapid-case-review-microlearning-activity-2","published_at":"2026-09-14T16:00:00+00:00","page_url":"https://stenobird.com/podcast/gynecologic-oncology-update-612940/low-grade-serous-ovarian-cancer-rapid-case-review-microlearning-activity-2","show_page_url":"https://stenobird.com/podcast/gynecologic-oncology-update-612940","url":"https://gynecologic-oncology.captivate.fm/episode/6128-lgso2026-2-rapidcasereview","audio_url":"https://dts.podtrac.com/redirect.mp3/episodes.captivate.fm/episode/4e030fa4-91a4-4b2b-b26c-563fb3bfc43d.mp3","summary":"Featuring perspectives from Dr Rachel N Grisham, including the following topics: Case: A woman in her early 40s with recurrent low-grade serous ovarian cancer (LGSOC) and prior treatment with a MEK inhibitor receives avutometinib/defactinib on the RAMP 301 trial (0:00) Case: A woman in her early 70s with recurrent KRAS-mutated LGSOC receives avutometinib/defactinib and develops muscle weakness (10:03) Case: A woman in her late 70s with KRAS-mutated recurrent LGSOC develops congestive heart failure on trametinib and then receives avutometinib/defactinib (16:15) Case: A woman in her mid 60s with recurrent BRAF V600E LGSOC has concerns about side effects and receives single-agent dabrafenib (19:49) CME information and select publications","meta_description":"Featuring perspectives from Dr Rachel N Grisham, including the following topics: Case: A woman in her early 40s with recurrent low-grade serous ovarian ca…","key_points":[],"chapters":[],"topics":[],"duration_seconds":1581,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/gynecologic-oncology-update-612940/episodes/low-grade-serous-ovarian-cancer-rapid-case-review-microlearning-activity-2/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/gynecologic-oncology-update-612940/low-grade-serous-ovarian-cancer-rapid-case-review-microlearning-activity-2.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}